The rising prevalence in GLP-1 agonists for diabetes has sparked a debate about formats: transdermal systems versus tablets . Traditionally , GLP-1 therapies were solely available in tablet form, but the https://nannietpaz955611.blazingblog.com/40985935/glp-1-transdermal-delivery-systems-vs-oral-medications-what-right-for-the-patient